1 / 3

Cycles of PLD/Carboplatin Received (n=58)

Cycles of PLD/Carboplatin Received (n=58). Adapted from: ESGO 2007, Berlin. Progression-free Survival* (n=58). 100%. Time to progression (months) Median (10.5) Maximum (22.5) Minimum (1.6). 80%. 60%. Patients (%). 40%. 20%. 0%. Months. 0. 3. 6. 9. 12. 15. 18. 21. 24.

winona
Download Presentation

Cycles of PLD/Carboplatin Received (n=58)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cycles of PLD/Carboplatin Received (n=58) Adapted from: ESGO 2007, Berlin.

  2. Progression-free Survival* (n=58) 100% Time to progression (months) Median (10.5) Maximum (22.5) Minimum (1.6) 80% 60% Patients (%) 40% 20% 0% Months 0 3 6 9 12 15 18 21 24 * 78% progressed at the time of analysis Adapted from: ESGO 2007, Berlin.

  3. CALYPSO: Major Non-hematological Toxicities Adapted from: Wagner et al. ESGO 2007, Berlin.

More Related